C Russell Trenary Iii Outlook Therapeutics, Inc. (OTLK) insider trading activity

OTLK Quotes by TradingView

C Russell Trenary Iii is CEO AND PRESIDENT of Outlook Therapeutics, Inc.. Currently has a direct ownership of 54,925 shares of OTLK, which is worth approximately $77,993. The most recent transaction as insider was on Jun 21, 2022, when has been sold 19,925 shares (Common Stock) at a price of $1.06 per share, resulting in proceeds of $21,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.9K
0% 3M change
0% 12M change
Total Value Held $77,993

C RUSSELL TRENARY III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2022
BUY
Open market or private purchase
$21,120 $1.06 p/Share
19,925 Added 26.62%
54,925 Common Stock
Dec 06 2021
BUY
Open market or private purchase
$34,750 $1.39 p/Share
25,000 Added 41.67%
35,000 Common Stock
Dec 02 2021
BUY
Open market or private purchase
$14,000 $1.4 p/Share
10,000 Added 50.0%
10,000 Common Stock
CRT

C Russell Trenary Iii

CEO AND PRESIDENT
Iselin, NJ

Track Institutional and Insider Activities on OTLK

Follow Outlook Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Insider Trading

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

News

Receive news related to Outlook Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLK